vs

Side-by-side financial comparison of MID PENN BANCORP INC (MPB) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

MID PENN BANCORP INC is the larger business by last-quarter revenue ($62.0M vs $37.2M, roughly 1.7× Organogenesis Holdings Inc.). On growth, MID PENN BANCORP INC posted the faster year-over-year revenue change (30.8% vs -57.1%). Over the past eight quarters, MID PENN BANCORP INC's revenue compounded faster (21.1% CAGR vs -46.5%).

Commerce Bancorp was a Cherry Hill, New Jersey–based bank created in 1973. In 2007, it was purchased by Toronto-Dominion Bank, which merged Commerce into TD Banknorth, the latter of which was rebranded to TD Bank.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

MPB vs ORGO — Head-to-Head

Bigger by revenue
MPB
MPB
1.7× larger
MPB
$62.0M
$37.2M
ORGO
Growing faster (revenue YoY)
MPB
MPB
+87.8% gap
MPB
30.8%
-57.1%
ORGO
Faster 2-yr revenue CAGR
MPB
MPB
Annualised
MPB
21.1%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MPB
MPB
ORGO
ORGO
Revenue
$62.0M
$37.2M
Net Profit
$19.4M
Gross Margin
30.8%
Operating Margin
43.6%
-185.1%
Net Margin
31.4%
Revenue YoY
30.8%
-57.1%
Net Profit YoY
47.0%
EPS (diluted)
$0.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MPB
MPB
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$62.0M
$225.6M
Q3 25
$61.8M
$150.9M
Q2 25
$54.3M
$101.0M
Q1 25
$47.7M
$86.7M
Q4 24
$47.4M
$126.7M
Q3 24
$45.3M
$115.2M
Q2 24
$44.1M
$130.2M
Net Profit
MPB
MPB
ORGO
ORGO
Q1 26
Q4 25
$19.4M
$43.7M
Q3 25
$18.3M
$21.6M
Q2 25
$4.8M
$-9.4M
Q1 25
$13.7M
$-18.8M
Q4 24
$13.2M
$7.7M
Q3 24
$12.3M
$12.3M
Q2 24
$11.8M
$-17.0M
Gross Margin
MPB
MPB
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
MPB
MPB
ORGO
ORGO
Q1 26
-185.1%
Q4 25
43.6%
28.1%
Q3 25
39.3%
13.7%
Q2 25
7.9%
-12.5%
Q1 25
35.2%
-30.9%
Q4 24
34.1%
8.1%
Q3 24
32.8%
5.4%
Q2 24
32.4%
-10.7%
Net Margin
MPB
MPB
ORGO
ORGO
Q1 26
Q4 25
31.4%
19.4%
Q3 25
29.6%
14.3%
Q2 25
8.8%
-9.3%
Q1 25
28.8%
-21.7%
Q4 24
27.9%
6.1%
Q3 24
27.1%
10.7%
Q2 24
26.7%
-13.1%
EPS (diluted)
MPB
MPB
ORGO
ORGO
Q1 26
Q4 25
$0.83
$0.31
Q3 25
$0.79
$0.11
Q2 25
$0.22
$-0.10
Q1 25
$0.71
$-0.17
Q4 24
$0.72
$0.05
Q3 24
$0.74
$0.09
Q2 24
$0.71
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MPB
MPB
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$814.1M
Total Assets
$6.1B
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MPB
MPB
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Total Debt
MPB
MPB
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
MPB
MPB
ORGO
ORGO
Q1 26
Q4 25
$814.1M
$300.1M
Q3 25
$796.3M
$255.1M
Q2 25
$775.7M
$233.2M
Q1 25
$667.9M
$242.9M
Q4 24
$655.0M
$262.9M
Q3 24
$573.1M
$278.5M
Q2 24
$559.7M
$263.5M
Total Assets
MPB
MPB
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$6.1B
$598.7M
Q3 25
$6.3B
$509.8M
Q2 25
$6.4B
$461.1M
Q1 25
$5.5B
$467.4M
Q4 24
$5.5B
$497.9M
Q3 24
$5.5B
$446.3M
Q2 24
$5.4B
$443.2M
Debt / Equity
MPB
MPB
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MPB
MPB
ORGO
ORGO
Operating Cash FlowLast quarter
$80.0M
Free Cash FlowOCF − Capex
$71.8M
FCF MarginFCF / Revenue
115.8%
Capex IntensityCapex / Revenue
13.3%
Cash ConversionOCF / Net Profit
4.12×
TTM Free Cash FlowTrailing 4 quarters
$132.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MPB
MPB
ORGO
ORGO
Q1 26
Q4 25
$80.0M
$39.4M
Q3 25
$26.3M
$3.1M
Q2 25
$29.0M
$-32.9M
Q1 25
$11.5M
$-19.9M
Q4 24
$51.4M
$10.9M
Q3 24
$16.9M
$8.7M
Q2 24
$18.0M
$4.7M
Free Cash Flow
MPB
MPB
ORGO
ORGO
Q1 26
Q4 25
$71.8M
$34.8M
Q3 25
$24.3M
$844.0K
Q2 25
$27.2M
$-36.5M
Q1 25
$8.8M
$-23.6M
Q4 24
$44.5M
$7.6M
Q3 24
$16.8M
$6.1M
Q2 24
$17.7M
$2.9M
FCF Margin
MPB
MPB
ORGO
ORGO
Q1 26
Q4 25
115.8%
15.4%
Q3 25
39.4%
0.6%
Q2 25
50.1%
-36.1%
Q1 25
18.4%
-27.2%
Q4 24
93.8%
6.0%
Q3 24
37.1%
5.3%
Q2 24
40.2%
2.2%
Capex Intensity
MPB
MPB
ORGO
ORGO
Q1 26
Q4 25
13.3%
2.1%
Q3 25
3.1%
1.5%
Q2 25
3.2%
3.6%
Q1 25
5.7%
4.2%
Q4 24
14.6%
2.7%
Q3 24
0.0%
2.2%
Q2 24
0.7%
1.4%
Cash Conversion
MPB
MPB
ORGO
ORGO
Q1 26
Q4 25
4.12×
0.90×
Q3 25
1.44×
0.14×
Q2 25
6.08×
Q1 25
0.84×
Q4 24
3.88×
1.43×
Q3 24
1.37×
0.71×
Q2 24
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons